financetom
Business
financetom
/
Business
/
Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
Jul 5, 2024 8:59 AM

11:43 AM EDT, 07/05/2024 (MT Newswires) -- Novo Nordisk ( NVO ) was publicly reprimanded Friday by industry regulators in the UK for not disclosing payments amounting to roughly 7.8 million pounds ($10 million) within a three-year period.

The Prescription Medicines Code of Practice Authority, or PMCPA, also said Novo Nordisk ( NVO ), Novartis ( NVS ) and Pfizer ( PFE ) had breached the Association of the British Pharmaceutical Industry's Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the industry. The code is administered by the PMCPA.

The three companies along with Otsuka will be named in advertisements for breaches of the ABPI Code, scheduled to appear in the BMJ on July 13 and the Nursing Standard on July 25, according to the PMCPA.

The regulators' reprimand followed Novo Nordisk's ( NVO ) voluntary admission to the body about undisclosed payments to more than 150 organizations between 2020 and 2022, the self-regulatory body said.

Novo Nordisk ( NVO ) said it had conducted internal investigations regarding the payments as part of a review of its compliance systems.

"These payments are for legitimate activities but had been incorrectly categorised in finance systems as a result of human error," the company said in a statement to MT Newswires, adding that it accepted the regulators' decision.

The PMCPA also said Novartis ( NVS ) breached the ABPI Code for failing to provide up-to-date prescribing information regarding hypertension drug Entresto, while Pfizer ( PFE ) breached the code for promoting an unlicensed vaccine on social media.

Novartis ( NVS ) expressed regret over the breach. "We continually review internal policies across our organization to ensure adherence to UK compliance regulations and remain committed to being a responsible partner for patients and the healthcare system," the company said in statement to MT Newswires.

Pfizer ( PFE ) did not immediately respond to MT Newswires' request for comment.

Price: 141.86, Change: +2.99, Percent Change: +2.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Twilio Q2 revenue up 13%, beats analyst expectations
Twilio Q2 revenue up 13%, beats analyst expectations
Aug 7, 2025
Overview * Twilio ( TWLO ) Q2 revenue of $1.23 bln, up 13% yr/yr, beats analyst expectations, per LSEG data * Non-GAAP income from operations rose 26% yr/yr to $221 mln * Twilio ( TWLO ) repurchased $176.7 mln in Class A shares in Q2 Outlook * Twilio ( TWLO ) sees Q3 revenue between $1.245 bln and $1.255 bln...
Beauty Health Co's Q2 revenue beats estimates
Beauty Health Co's Q2 revenue beats estimates
Aug 7, 2025
Overview * Beauty Health Q2 2025 net sales fall 13.7% yr/yr, beating analyst expectations * Adjusted EBITDA for Q2 2025 beats consensus, driven by improved gross margins * Company raises full-year guidance, reflecting confidence in strategic transformation Outlook * Beauty Health ( SKIN ) expects full-year 2025 net sales guidance of $285-$300 mln * Company expects Q3 2025 net sales...
Canada's Sun Life Q2 adjusted EPS beats expectations
Canada's Sun Life Q2 adjusted EPS beats expectations
Aug 7, 2025
Overview * Sun Life Q2 underlying net income rises 2%, beating analyst expectations * Adjusted EPS for Q2 beats consensus, indicating strong operational performance * Company repurchased CAD 400 mln of shares, maintaining strong capital position Outlook * Sun Life maintains strong capital position with LICAT ratio of 151% * Company emphasizes resilience in business mix amid external uncertainties *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved